Long term efficacy and tolerability of indiplon-ir in the treatment of chronic insomnia: Results of a double-blind, placebo-controlled 3-month study

被引：0
|
作者：
Scharf, MB
Black, J
Hull, S
Mahowald, M
Moscovitch, A
Farber, R
Jochelson, P
机构：
[1] Tri State Sleep Disorders Ctr, Cincinnati, OH USA
[2] Sleep Clin San Francisco, San Francisco, CA USA
[3] Vince & Associates Clin Res, Overland Pk, KS USA
[4] Minnesota Reg Sleep Disorders Ctr, Minneapolis, MN USA
[5] CSI Res Ctr, Calgary, AB, Canada
[6] Neurocrine Biosci, San Diego, CA USA
来源：
SLEEP | 2005年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
682
引用
收藏
页码：A229 / A229
页数：1
相关论文
共 50 条
  • [1] Long-term nightly treatment with indiplon in adults with chronic insomnia: Results of a double-blind, placebo-controlled, 3-month study
    Farber, R
    Scharf, MB
    Black, J
    Landin, R
    [J]. NEUROLOGY, 2006, 66 (05) : A9 - A9
  • [2] Long-term nightly treatment with indiplon in adults with primary insomnia: Results of a double-blind, placebo-controlled, 3-month study
    Scharf, Martin B.
    Black, Jed
    Hull, Steven
    Landin, Rick
    Farber, Robert
    [J]. SLEEP, 2007, 30 (06) : 743 - 752
  • [3] Efficacy and tolerability of indiplon in adults with chronic insomnia: Results from two double-blind, placebo-controlled trials
    Klee, B.
    Keohane, D.
    Bell, J.
    Farber, R.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 : 48 - 48
  • [4] Efficacy and tolerability of indiplon in primary insomnia: Results of a double-blind, placebo-controlled, 4-week trial
    Lankford, D.
    Klee, B.
    Kean, Y.
    Farber, R.
    [J]. SLEEP, 2006, 29 : A256 - A256
  • [5] Efficacy and tolerability of gaboxadol in adults with primary insomnia: A 3-month, randomized, double-blind, placebo-controlled trial
    Anderson, D.
    Roth, T.
    Zheng, Y.
    Vandormael, K.
    Smith, A.
    Li, M.
    Digravio, D.
    [J]. SLEEP, 2007, 30 : A234 - A234
  • [6] Efficacy and tolerability of Indiplon-MR in elderly patients with chronic insomnia: Results of a double-blind, placebo-controlled, 2-week trial
    Lankford, J
    Lydiard, R
    Walsh, JK
    Seiden, D
    Jochelson, P
    [J]. SLEEP, 2005, 28 : A230 - A230
  • [7] Efficacy and tolerability of myrtol standardized in long-term treatment of chronic bronchitis - A double-blind, placebo-controlled study
    Meister, R
    Wittig, T
    Beuscher, N
    de Mey, C
    [J]. ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1999, 49 (04): : 351 - 358
  • [8] Efficacy and Tolerability of Modified-Release Indiplon in Elderly Patients With Chronic Insomnia: Results of a 2-Week Double-Blind, Placebo-Controlled Trial
    Lydiard, R. Bruce
    Lankford, D. Alan
    Seiden, David J.
    Landin, Rick
    Farber, Robert
    Walsh, James K.
    [J]. JOURNAL OF CLINICAL SLEEP MEDICINE, 2006, 2 (03): : 309 - 315
  • [9] Phase 3 Placebo-Controlled Study of Galcanezumab in Patients with Chronic Cluster Headache: Results from 3-Month Double-Blind Treatment
    Oakes, T. M.
    Dodick, D. W.
    Goadsby, P. J.
    Lucas, C.
    Jensen, R.
    Bardos, J.
    Martinez, J.
    Zhou, C.
    Aurora, S. K.
    Yang, J.
    Conley, R.
    [J]. HEADACHE, 2019, 59 : 19 - 20
  • [10] Efficacy and tolerability of gaboxadol in elderly patients with chronic primary insomnia: A 6-month double-blind, placebo-controlled outpatient study
    Hedner, J.
    Loft, H.
    Hajak, G.
    Lundahl, J.
    Hedegaard, K.
    Knoth, Sorensen H.
    Torstenson, R.
    [J]. SLEEP, 2007, 30 : A252 - A253
12345